Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
20.06.2024 |
18.06.2024 |
17.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0006
|
0.0045
|
0.0007
|
0.0006
|
0.0007
|
0.0006
|
|
|
26.17
|
16.00
|
0.0006
|
0.0009
|
0.0013
|
0.0007
|
0.0013
|
0.0007
|
|
|
67.99
|
22.00
|
0.0006
|
0.01
|
0.0013
|
0.0012
|
0.0013
|
0.0012
|
|
|
7.75
|
7.00
|
0.0007
|
0.01
|
0.002
|
0.0012
|
0.002
|
0.0012
|
|
|
42.03
|
8.00
|
0.0007
|
0.0027
|
0.002
|
0.0006
|
0.002
|
0.0012
|
|
|
108.03
|
54.00
|
0.0007
|
0.01
|
0.001
|
0.001
|
0.004
|
0.0027
|
|
|
366.10
|
105.00
|
0.0012
|
0.01
|
0.0201
|
0.0005
|
0.0389
|
0.0011
|
|
|
7 100.04
|
852.00
|
0.0201
|
0.057
|
0.0385
|
0.025
|
0.0385
|
0.0275
|
|
|
70.21
|
13.00
|
0.0201
|
0.057
|
0.0214
|
0.0201
|
0.0214
|
0.0202
|
|
|
296.47
|
11.00
|
0.0211
|
0.07
|
0.0389
|
0.0389
|
0.0389
|
0.0389
|
|
|
3.89
|
1.00
|
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs known as selective translation regulator inhibitors (STRIs).